Intercept shares dive after FDA safety alert on liver drug
Regulator warns of death risk in patients on higher than recommended dose.
Regulator warns of death risk in patients on higher than recommended dose.
NHS patients to get access to drug in PBC.
Sales forecast to reach $2.6 billion in 2020.